| ［1］ |
Thornton CS, Mellett M, Jarand J, et al. The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health［J］. Eur Respir Rev, 2021,30（160）:200299. doi: 10.1183/16000617.0299⁃2020.
|
| ［2］ |
中华医学会结核病学分会分枝杆菌菌种中文译名原则专家共识编写组. 分枝杆菌菌种中文译名原则专家共识［J］. 中华结核和呼吸杂志, 2018,41（7）:522⁃528. doi: 10.3760/cma.j.issn. 1001⁃0939.2018.07.003
|
| ［3］ |
Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey［J］. Infect Dis Poverty, 2021,10（1）:59. doi: 10.1186/s40249⁃021⁃00844⁃1.
|
| ［4］ |
Zhang X, Liu W, Liu W, et al. Cutaneous infections caused by rapidly growing mycobacteria: case reports and review of clinical and laboratory aspects［J］. Acta Derm Venereol, 2015,95（8）:985⁃989. doi:10.2340/00015555⁃2105.
|
| ［5］ |
Singhal N, Kumar M, Kanaujia PK, et al. MALDI⁃TOF mass spectrometry: an emerging technology for microbial identification and diagnosis［J］. Front Microbiol, 2015,6:791. doi: 10.3389/fmicb.2015.00791.
|
| ［6］ |
Kothavade RJ, Dhurat RS, Mishra SN, et al. Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria［J］. Eur J Clin Microbiol Infect Dis, 2013,32（2）:161⁃188. doi: 10.1007/s10096⁃012⁃1766⁃8.
|
| ［7］ |
Shulha JA, Escalante P, Wilson JW. Pharmacotherapy approaches in nontuberculous mycobacteria infections［J］. Mayo Clin Proc, 2019,94（8）:1567⁃1581. doi: 10.1016/j.mayocp.2018. 12.011.
|
